v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
SALES    
Total sales $ 113,771 $ 62,874
Cost of goods 45,156 45,156
Gross profit 68,615 17,718
COST OF OPERATIONS    
Research and development expense 235,529 86,659
Salary expense 422,705 439,173
Amortization expense 250,000 250,000
Professional services expense 1,014,144 2,325,567
Stock based compensation expense 1,416,178 597,731
General and administrative expenses 644,703 269,072
Selling and marketing expense 0 106,500
Total cost of operations 3,983,259 4,074,702
LOSS FROM OPERATIONS (3,914,644) (4,056,984)
OTHER (EXPENSE) INCOME    
Interest expense (5,257) (71,491)
Other income, net 32,206 111,414
Unrealized loss on marketable securities (176,045) 0
Unrealized loss on investments (22,688) 0
Realized gain on sale of marketable securities 85,407 0
Change in fair value of derivative liabilities (19,875) 596,120
TOTAL OTHER (EXPENSE) INCOME, net (106,252) 636,043
LOSS BEFORE INCOME TAXES (4,020,896) (3,420,941)
PROVISION FOR INCOME TAXES (BENEFIT) 0 0
NET LOSS (4,020,896) (3,420,941)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS (3,916,618) (3,356,538)
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS (104,278) (64,403)
NET LOSS $ (4,020,896) $ (3,420,941)
LOSS PER SHARE    
Loss per share, basic $ (0.65) $ (1.10)
Loss per share, fully diluted $ (0.65) $ (1.10)
Weighted average number of common shares outstanding, basic 6,032,193 3,073,074
Weighted average number of common shares outstanding, diluted 6,032,193 3,073,074
Sales 1 [Member]    
SALES    
Total sales $ 113,771 $ 62,874